The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time-of-day infusion of immunotherapy may impact outcomes in advanced non-small cell lung cancer patients (NSCLC).
 
Carlos H. Barrios
Stock and Other Ownership Interests - MedSIR; Tummi
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi; Zodiac Pharma
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Libbs; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; United Medical
Research Funding - AB Science (Inst); Abbvie (Inst); Abraxis BioScience (Inst); Amgen (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clinica Atlantis (Inst); Covance (Inst); Daiichi Sankyo (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); ImClone Systems (Inst); INC Research (Inst); inVentiv Health (Inst); Janssen (Inst); LEO Pharma (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merrimack (Inst); Millennium (Inst); Mylan (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Polyphor (Inst); Roche/Genentech (Inst); Sanofi (Inst); Shanghai Henlius Biotech (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Tatiane Caldas Montella
No Relationships to Disclose
 
Carlos G. M. Ferreira
No Relationships to Disclose
 
Pedro De Marchi
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; Merck Sharp & Dohme; Novartis; Roche; Takeda
Research Funding - Amgen; AstraZeneca; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Luiz Flavio Coutinho
No Relationships to Disclose
 
Igor Lemos Duarte
Stock and Other Ownership Interests - Grupo Oncoclinicas
Honoraria - BMS Brazil
Consulting or Advisory Role - BMS Brazil
Speakers' Bureau - AstraZeneca; BMS Brazil
 
Matheus Costa e Silva
Employment - Grupo Oncoclínicas; Rede D'Or São Luiz
 
Rafael Duarte Paes
Speakers' Bureau - Amgen; Libbs; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Guilherme Munhoz Correia e Silva
No Relationships to Disclose
 
Rodrigo Dienstmann
Employment - Oncoclínicas
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Amgen; Ipsen; Libbs; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Merck